Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
An update from Verrica Pharmaceuticals ( (VRCA) ) is now available.
Verrica Pharmaceuticals Inc. has appointed David Zawitz as its new Chief Operating Officer, effective December 9, 2024. Zawitz, who has an extensive legal and financial background, including roles at PBM Capital Group and CarMax, will receive an annual salary of $250,000 and is eligible for stock options and bonuses. This strategic move is part of the company’s broader plan to expand its stock option pool, aiming to attract top talent and strengthen its position in the financial market.
Learn more about VRCA stock on TipRanks’ Stock Analysis page.
